Guggenheim Capital LLC increased its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 315,461 shares of the medical research company’s stock after buying an additional 17,552 shares during the period. Guggenheim Capital LLC owned 0.08% of Thermo Fisher Scientific worth $59,899,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of TMO. Ark Investment Management LLC boosted its holdings in shares of Thermo Fisher Scientific by 2.8% during the 2nd quarter. Ark Investment Management LLC now owns 18,005 shares of the medical research company’s stock worth $3,141,000 after buying an additional 488 shares during the period. Mutual of America Capital Management LLC boosted its holdings in shares of Thermo Fisher Scientific by 2.2% during the 3rd quarter. Mutual of America Capital Management LLC now owns 48,772 shares of the medical research company’s stock worth $9,228,000 after buying an additional 1,044 shares during the period. Hermes Investment Management Ltd. boosted its holdings in shares of Thermo Fisher Scientific by 10.2% during the 3rd quarter. Hermes Investment Management Ltd. now owns 604,989 shares of the medical research company’s stock worth $114,464,000 after buying an additional 55,912 shares during the period. FormulaFolio Investments LLC bought a new stake in shares of Thermo Fisher Scientific during the 3rd quarter worth $850,000. Finally, Diamond Hill Capital Management Inc. boosted its holdings in shares of Thermo Fisher Scientific by 50.5% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 1,075,604 shares of the medical research company’s stock worth $203,504,000 after buying an additional 360,911 shares during the period. 87.67% of the stock is owned by institutional investors and hedge funds.
In other news, Director William G. Parrett sold 1,000 shares of the stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $209.80, for a total value of $209,800.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction on Friday, December 15th. The shares were sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the transaction, the chief executive officer now owns 302,577 shares of the company’s stock, valued at approximately $58,016,113.98. The disclosure for this sale can be found here. In the last 90 days, insiders sold 98,827 shares of company stock valued at $20,193,272. Corporate insiders own 0.49% of the company’s stock.
Thermo Fisher Scientific Inc. (NYSE:TMO) opened at $215.12 on Wednesday. The company has a market cap of $87,384.02, a price-to-earnings ratio of 38.41, a P/E/G ratio of 1.59 and a beta of 1.15. Thermo Fisher Scientific Inc. has a one year low of $151.74 and a one year high of $226.44. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.92 and a current ratio of 1.34.
Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, January 31st. The medical research company reported $2.79 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.66 by $0.13. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $5.72 billion. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The business’s quarterly revenue was up 22.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.41 EPS. equities analysts predict that Thermo Fisher Scientific Inc. will post 10.81 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Investors of record on Thursday, March 15th will be paid a dividend of $0.17 per share. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a yield of 0.32%. The ex-dividend date of this dividend is Wednesday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.71%.
WARNING: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international trademark and copyright law. The legal version of this piece can be read at https://www.americanbankingnews.com/2018/03/14/guggenheim-capital-llc-acquires-17552-shares-of-thermo-fisher-scientific-inc-tmo.html.
Thermo Fisher Scientific Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.